Kamal Patel

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 110 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Biomarkers in inflammatory bowel disease: a practical guide

Michael Colwill, Andrew Poullis, Richard Pollok et al. · Therapeutic Advances in Gastroenterology · 2024 · 78 citations · Full text

Medicine, Clinical Sciences, Immunology +17

Self-rated health supersedes patient satisfaction with service quality as a predictor of survival in prostate cancer

Digant Gupta, Kamal Patel, C. G. Lis · Health and Quality of Life Outcomes · 2015 · 29 citations · Full text

Pharmacy, Oncology, Health Assessment +16

Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)

Nizar M. Tannir, Maria Nirvana Formiga, Konstantin Penkov et al. · Journal of Clinical Oncology · 2024 · 24 citations

Medicine, Immunology, Oncology +17